|
AT280356B
(de)
|
1968-03-06 |
1970-04-10 |
Telefonbau & Normalzeit Gmbh |
Schaltungsanordnung zur Steuerung des zur Zwischenspeicherung des Zeitwertes eines Signales verwendeten Kondensators eines Demodulators einer Zeitmultiplexanlage
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
CH660375A5
(it)
|
1983-02-08 |
1987-04-15 |
Sclavo Spa |
Procedimento per la produzione di proteine correlate alla tossina difterica.
|
|
US4708871A
(en)
|
1983-03-08 |
1987-11-24 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4650764A
(en)
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
|
US4668829A
(en)
*
|
1984-07-18 |
1987-05-26 |
University Patents, Inc. |
Ferroelectric smectic liquid crystals
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
GB8424757D0
(en)
|
1984-10-01 |
1984-11-07 |
Pasteur Institut |
Retroviral vector
|
|
SE8405493D0
(sv)
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
|
EP0232262A4
(en)
|
1985-08-15 |
1989-09-19 |
Stauffer Chemical Co |
TRYPTOPHANE GENERATING MICROORGANISM.
|
|
US5078996A
(en)
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
DE3689123T2
(de)
|
1985-11-01 |
1994-03-03 |
Xoma Corp |
Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
RU2023448C1
(ru)
|
1987-07-30 |
1994-11-30 |
Сентро Насьональ Де Биопрепарадос |
Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
|
|
JPH01144977A
(ja)
|
1987-11-30 |
1989-06-07 |
Agency Of Ind Science & Technol |
新規組換えプラスミドｐＴＰＧＩＦ２
|
|
AU3069189A
(en)
|
1988-02-05 |
1989-08-25 |
Trustees Of Columbia University In The City Of New York, The |
Retroviral packaging cell lines and processes of using same
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
EP0432216A1
(en)
|
1988-09-01 |
1991-06-19 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US7118757B1
(en)
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
|
US5124263A
(en)
|
1989-01-12 |
1992-06-23 |
Wisconsin Alumni Research Foundation |
Recombination resistant retroviral helper cell and products produced thereby
|
|
CA2047681C
(en)
|
1989-03-09 |
2000-02-01 |
Bruce A. Green |
Vaccines for nontypable haemophilus influenzae
|
|
US5354844A
(en)
|
1989-03-16 |
1994-10-11 |
Boehringer Ingelheim International Gmbh |
Protein-polycation conjugates
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
EP0467714A1
(en)
|
1990-07-19 |
1992-01-22 |
Merck & Co. Inc. |
The class II protein of the outer membrane of neisseria meningitidis
|
|
JPH0453645U
(enExample)
*
|
1990-09-12 |
1992-05-07 |
|
|
|
EP0953648A3
(en)
|
1990-09-25 |
2007-09-12 |
Cantab Pharmaceuticals Research Limited |
Viral defective vaccine produced by transcomplementing cell line
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
|
AU681572B2
(en)
|
1991-10-21 |
1997-09-04 |
Med Immune, Inc. |
Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
|
WO1993015115A1
(en)
|
1992-01-24 |
1993-08-05 |
Cornell Research Foundation, Inc. |
E. coli dna polymerase iii holoenzyme and subunits
|
|
EP0673431A1
(en)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
EP0616034B1
(en)
|
1993-03-05 |
2004-10-20 |
Wyeth Holdings Corporation |
Plasmid for production of CRM protein and diphtheria toxin
|
|
AU696336B2
(en)
|
1993-03-19 |
1998-09-10 |
Cantab Pharmaceuticals Research Limited |
Defective mutant non-retroviral virus (e.g. HSV) as vaccine
|
|
DK0624376T3
(da)
|
1993-05-13 |
2000-07-24 |
American Cyanamid Co |
Fremstilling og anvendelse af LOS-udtømte ydre membranproteiner af gram-negative cocci
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
ES2310924T3
(es)
|
1993-07-13 |
2009-01-16 |
Centelion |
Vectores adenovirales defectivos y utilizacion en terapia genica.
|
|
US5439808A
(en)
*
|
1993-07-23 |
1995-08-08 |
North American Vaccine, Inc. |
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
|
|
AU7477394A
(en)
|
1993-07-30 |
1995-03-27 |
University Of Medicine And Dentistry Of New Jersey |
Efficient gene transfer into primary lymphocytes
|
|
FR2708622B1
(fr)
|
1993-08-02 |
1997-04-18 |
Raymond Hamers |
Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
|
|
US5550213A
(en)
|
1993-12-27 |
1996-08-27 |
Rutgers, The State University Of New Jersey |
Inhibitors of urokinase plasminogen activator
|
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FI98045C
(fi)
|
1994-02-21 |
1997-04-10 |
Arto Remes |
Laite inkontinenssihoitoa varten
|
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
|
WO1995026411A2
(en)
|
1994-03-25 |
1995-10-05 |
The Uab Research Foundation |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
WO1995028494A1
(en)
|
1994-04-15 |
1995-10-26 |
Targeted Genetics Corporation |
Gene delivery fusion proteins
|
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
|
ES2128055T3
(es)
*
|
1994-04-20 |
1999-05-01 |
Us Army |
Vacuna contra infecciones de bacterias gram-negativas.
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5837533A
(en)
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
|
GB9422096D0
(en)
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
|
FR2727679B1
(fr)
|
1994-12-05 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
|
BE1008978A5
(fr)
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
WO1996039036A1
(en)
|
1995-06-05 |
1996-12-12 |
The University Of Alabama At Birmingham Research Foundation |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
|
EP1741718A3
(en)
*
|
1995-06-07 |
2007-03-28 |
Sanofi Pasteur Inc. |
Expression of lipoproteins
|
|
FR2741358B1
(fr)
|
1995-11-17 |
1998-01-02 |
Centre Nat Rech Scient |
Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
|
|
CU22559A1
(es)
*
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
|
US6355255B1
(en)
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
ATE208629T1
(de)
|
1996-08-27 |
2001-11-15 |
Chiron Corp |
Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
|
|
EP0922059B1
(en)
|
1996-08-27 |
2003-10-22 |
Chiron Corporation |
Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
|
|
WO1998017805A2
(en)
|
1996-10-24 |
1998-04-30 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Office |
Invasion associated genes from neisseria meningitidis serogroup b
|
|
GB9622159D0
(en)
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
|
GB9622660D0
(en)
|
1996-10-31 |
1997-01-08 |
Biocine Spa |
Immunogenic detoxified mutant toxin
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
DE19723095C2
(de)
|
1997-06-02 |
2001-08-23 |
Siemens Ag |
Bildrekonstruktionsverfahren für einen Computertomographen
|
|
BR9810369A
(pt)
|
1997-06-30 |
2000-09-05 |
Rhone Poulenc Rorer Sa |
Processo de transferência de ácido nucleico para o interior de um ou mais músculos estriados, in vivo, composição, ácido mucleico e campo elétrico, e, produto de combinação
|
|
AU8444698A
(en)
|
1997-06-30 |
1999-01-25 |
Centre National De La Recherche Scientifique |
Improved method for transferring nucleic acid into multicelled eukaryo tic organism cells and combination therefor
|
|
WO1999001175A1
(en)
|
1997-06-30 |
1999-01-14 |
Rhone-Poulenc Rorer S.A. |
Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
|
|
BR9811475A
(pt)
*
|
1997-07-17 |
2000-08-15 |
North American Vaccine Inc |
Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
|
|
JPH1144977A
(ja)
|
1997-07-25 |
1999-02-16 |
Copyer Co Ltd |
画像形成装置
|
|
DE69840508D1
(de)
|
1997-08-27 |
2009-03-12 |
Childrens Hosp Medical Center |
Molekular-mimetika von meningokokkus b epitopen
|
|
JP2001514269A
(ja)
*
|
1997-08-29 |
2001-09-11 |
ザ ダウ ケミカル カンパニー |
均質な、充填剤含有高分子複合体
|
|
AU9363798A
(en)
|
1997-11-06 |
1999-05-31 |
Chiron S.P.A. |
Neisserial antigens
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
ES2333071T5
(es)
|
1998-01-14 |
2015-08-17 |
Novartis Vaccines And Diagnostics S.R.L. |
Antígenos de Neisseria meningitidis
|
|
AU2313199A
(en)
*
|
1998-02-03 |
1999-08-23 |
Center For Disease Control And Prevention |
Recombinant lipidated psaa protein, methods of preparation and use
|
|
GB9806456D0
(en)
|
1998-03-25 |
1998-05-27 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
GB9808734D0
(en)
|
1998-04-23 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
|
ES2304065T3
(es)
*
|
1998-05-01 |
2008-09-01 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenos y composiciones de neisseria meningitidis.
|
|
ATE346609T1
(de)
|
1998-05-29 |
2006-12-15 |
Novartis Vaccines & Diagnostic |
Kombinierte meningitis b/c impfstoffe
|
|
JP4673974B2
(ja)
|
1998-09-30 |
2011-04-20 |
ワイス・ホールディングズ・コーポレイション |
アジュバントとしての変異コレラホロトキシン
|
|
EP1198245B1
(en)
|
1998-09-30 |
2004-08-25 |
Walter Reed Army Institute of Research |
Use of purified invaplex from gram negative bacteria as a vaccine
|
|
EP1144998A3
(en)
|
1998-10-09 |
2002-08-07 |
Chiron Corporation |
Neisseria genomic sequences and methods of their use
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6281337B1
(en)
|
1998-11-12 |
2001-08-28 |
Schering Corporation |
Methods for conversion of protein isoforms
|
|
AU2289000A
(en)
|
1999-01-15 |
2000-08-01 |
Smithkline Beecham Biologicals (Sa) |
(neisseria meningitidis) polypeptide basb052
|
|
WO2000043518A1
(en)
|
1999-01-22 |
2000-07-27 |
Smithkline Beecham Biologicals S.A. |
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
|
|
GB9902084D0
(en)
*
|
1999-01-29 |
1999-03-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
DK1150712T3
(da)
|
1999-02-05 |
2009-02-02 |
Merck & Co Inc |
Vaccineformuleringer mod human papillomavirus
|
|
CA2371994C
(en)
|
1999-02-26 |
2010-09-28 |
Guido Grandi |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
|
|
US6245568B1
(en)
|
1999-03-26 |
2001-06-12 |
Merck & Co., Inc. |
Human papilloma virus vaccine with disassembled and reassembled virus-like particles
|
|
US7115730B1
(en)
|
1999-04-27 |
2006-10-03 |
Chiron Srl |
Immunogenic detoxified mutant E. coli LT-A-toxin
|
|
ES2477194T3
(es)
|
1999-04-30 |
2014-07-16 |
Novartis Vaccines And Diagnostics S.R.L. |
Ant�genos neisseriales conservados
|
|
CA2371032A1
(en)
|
1999-04-30 |
2000-11-09 |
Chiron Corporation |
Neisseria genomic sequences and methods of their use
|
|
DK2270173T3
(en)
*
|
1999-05-19 |
2016-03-07 |
Glaxosmithkline Biolog Sa |
Neisserial combination compositions
|
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
GB9918319D0
(en)
*
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
US7384640B1
(en)
|
1999-09-30 |
2008-06-10 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant
|
|
CA2864069A1
(en)
|
1999-10-29 |
2001-05-03 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigenic peptides
|
|
GB9928196D0
(en)
*
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
ATE460484T1
(de)
|
1999-11-29 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
85 kda antigen von neisseria
|
|
DK1233784T3
(da)
|
1999-12-02 |
2008-09-01 |
Novartis Vaccines & Diagnostic |
Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
|
|
DK1248647T3
(da)
|
2000-01-17 |
2010-09-27 |
Novartis Vaccines & Diagnostic |
Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner
|
|
MXPA02008313A
(es)
|
2000-02-28 |
2002-12-09 |
Chiron Spa |
Expresion hibrida de proteinas de neisseria.
|
|
CZ304195B6
(cs)
|
2000-06-08 |
2013-12-27 |
Intercell Ag |
Imunostimulační farmaceutický přípravek
|
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
|
JP2005504718A
(ja)
|
2001-01-23 |
2005-02-17 |
アヴェンティス パストゥール |
多価髄膜炎菌多糖−タンパク質複合ワクチン
|
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
|
CA2441327A1
(en)
|
2001-03-30 |
2002-10-10 |
Geneprot, Inc. |
Human arginine-rich protein-related compositions
|
|
AU2002258734A1
(en)
|
2001-04-13 |
2002-10-28 |
Wyeth Holdings Corporation |
Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
|
|
EP1379272B1
(en)
|
2001-04-17 |
2010-01-20 |
Novartis Vaccines and Diagnostics, Inc. |
Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes
|
|
AU2002322380B2
(en)
|
2001-06-07 |
2006-11-02 |
Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences |
Mutant forms of cholera holotoxin as an adjuvant
|
|
WO2002098368A2
(en)
|
2001-06-07 |
2002-12-12 |
Wyeth Holdings Corporation |
Mutant forms of cholera holotoxin as an adjuvant
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
CA2452720C
(en)
|
2001-07-26 |
2012-04-17 |
Chiron S.R.L. |
Vaccines comprising aluminium adjuvants and histidine
|
|
GB0121591D0
(en)
*
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
EP1436385A4
(en)
|
2001-09-14 |
2005-12-14 |
Invitrogen Corp |
DNA POLYMERASES AND MUTANTS CORRESPONDING
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
GB0129007D0
(en)
|
2001-12-04 |
2002-01-23 |
Chiron Spa |
Adjuvanted antigenic meningococcal compositions
|
|
DK1490409T3
(da)
|
2002-03-26 |
2009-03-23 |
Novartis Vaccines & Diagnostic |
Modificerede saccharider med forbedret stabilitet i vand
|
|
JP4662537B2
(ja)
|
2002-05-14 |
2011-03-30 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
細菌性髄膜炎に関する粘膜組合せワクチン
|
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
|
MXPA04011249A
(es)
|
2002-05-14 |
2005-06-06 |
Chiron Srl |
Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos.
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
GB0220198D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
|
US8663656B2
(en)
|
2002-10-11 |
2014-03-04 |
Novartis Ag |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
|
US20070059329A1
(en)
|
2002-11-15 |
2007-03-15 |
Nathalie Norais |
Unexpected surface proteins in meningococcus
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
WO2004065603A2
(en)
|
2003-01-15 |
2004-08-05 |
Wyeth Holdings Corporation |
Methods for increasing neisseria protein expression
|
|
CA3042073C
(en)
|
2003-01-30 |
2022-09-13 |
Novartis Vaccines And Diagnostics S.R.L. |
Injectable vaccines against multiple meningococcal serogroups
|
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
JP2006525330A
(ja)
|
2003-04-16 |
2006-11-09 |
ワイエス・ホールディングス・コーポレーション |
髄膜炎菌性疾患の予防および処置のための新規免疫原性組成物
|
|
PT1631264E
(pt)
|
2003-06-02 |
2009-11-03 |
Novartis Vaccines & Diagnostic |
Composições imunogénicas à base de micropartículas biodegradáveis que compreendem um toxóide de difteria e do tétano
|
|
WO2005000345A2
(en)
|
2003-06-23 |
2005-01-06 |
Aventis Pasteur, Inc. |
Immunization method against neisseria meningitidis serogroups a and c
|
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
|
SI1670506T1
(sl)
|
2003-10-02 |
2013-03-29 |
Novartis Ag |
Tekoča cepiva proti multiplim meningokoknim seroskupinam
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
CN1901935A
(zh)
|
2003-12-30 |
2007-01-24 |
惠氏公司 |
具有改进耐受性的免疫原组合物中的疏水性蛋白调配物
|
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
|
GB0408978D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Meningococcal fermentation for preparing conjugate vaccines
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
|
EP2272531A3
(en)
|
2004-04-30 |
2011-04-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Integration of meningococcal conjugate vaccination
|
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
|
DE602005025647D1
(de)
|
2004-07-23 |
2011-02-10 |
Novartis Vaccines & Diagnostic |
Polypeptide für die oligomerisierung von antigenen
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
GB0419846D0
(en)
|
2004-09-07 |
2004-10-13 |
Chiron Srl |
Vaccine adjuvants for saccharides
|
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
HUE033196T2
(en)
|
2005-01-27 |
2017-11-28 |
Children's Hospital & Res Center At Oakland |
GNA1870-based vesicle vaccines for broad-spectrum protection against diseases caused by Neisseria meningitidis
|
|
JP2008533016A
(ja)
|
2005-03-07 |
2008-08-21 |
アイディー バイオメディカル コーポレイション オブ ケベック シー．オー．ビー． アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ |
薬学的リポソーム組成物
|
|
PT1885734E
(pt)
|
2005-05-06 |
2015-03-04 |
Novartis Ag |
Imunogénios para vacinas contra a meningite-a
|
|
JP2008543907A
(ja)
|
2005-06-27 |
2008-12-04 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
|
CA2621023C
(en)
|
2005-09-01 |
2019-07-02 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
Multiple vaccination including serogroup c meningococcus
|
|
CA2621578C
(en)
|
2005-09-05 |
2014-07-22 |
Glaxosmithkline Biologicals S.A. |
Serum bactericidal assay for n. meningitidis specific antisera
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
AU2006327023A1
(en)
|
2005-12-23 |
2007-06-28 |
Glaxosmithkline Biologicals Sa |
Conjugate vaccines
|
|
ES2383209T3
(es)
|
2006-03-22 |
2012-06-19 |
Novartis Ag |
Regímenes para la inmunización con conjugados meningococicos
|
|
US20070253985A1
(en)
|
2006-04-26 |
2007-11-01 |
Wyeth |
Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
CA2654706A1
(en)
|
2006-06-12 |
2007-12-21 |
Nathalie Devos |
Neisseria meningitidis lipooligosaccharide vaccine
|
|
GB0612854D0
(en)
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
|
RU2450019C2
(ru)
|
2006-06-29 |
2012-05-10 |
Новартис Аг |
Полипептиды из neisseria meningitidis
|
|
SI2061897T1
(sl)
|
2006-07-27 |
2020-07-31 |
Wyeth Llc |
Postopek fermentacije s tehniko dohranjevalne šarže za celice z visoko gostoto za proizvajanje rekombinantnega proteina
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
JP5637848B2
(ja)
|
2007-06-04 |
2014-12-10 |
ノバルティス アーゲー |
髄膜炎ワクチンの製剤化
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
EP2185576A4
(en)
|
2007-08-02 |
2011-01-12 |
Childrens Hosp & Res Ct Oak |
FHBP- AND LPXL1-BASED VESICIUM VACCINES FOR BROADBAND PROTECTION AGAINST NEISSERIA MENINGITIDIS-RELATED DISEASES
|
|
DK2200642T3
(da)
|
2007-10-19 |
2012-07-16 |
Novartis Ag |
Meningococvaccinepræparater
|
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
|
AU2009221180B2
(en)
|
2008-03-05 |
2014-02-13 |
Sanofi Pasteur |
Process for stabilizing an adjuvant containing vaccine composition
|
|
ES2557282T3
(es)
|
2008-03-10 |
2016-01-25 |
Children's Hospital & Research Center At Oakland |
Proteínas quiméricas de unión al factor H (fHBP) que contienen un dominio B heterólogo, y métodos de uso
|
|
US20100035234A1
(en)
|
2008-05-19 |
2010-02-11 |
Novartis Ag |
Vaccine assays
|
|
UA99659C2
(uk)
|
2008-05-30 |
2012-09-10 |
Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі |
Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
|
|
AU2009288242A1
(en)
|
2008-08-27 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Complement factor H-based assays for serum bactericidal activity against Neisseria meningitidis
|
|
CA2733943A1
(en)
|
2008-09-03 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
|
|
IT1394288B1
(it)
|
2008-09-12 |
2012-06-06 |
Novartis Vaccines & Diagnostic |
Immunogeni di proteine che legano il fattore h.
|
|
BRPI0919979A2
(pt)
|
2008-10-29 |
2015-12-15 |
Wyeth Llc |
formulações de moléculas de ligação de antígeno de domínio único
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
JP5410084B2
(ja)
*
|
2008-12-15 |
2014-02-05 |
川上産業株式会社 |
梱包箱及び箱状芯材
|
|
CA2747340A1
(en)
|
2008-12-17 |
2010-06-24 |
Novartis Ag |
Meningococcal vaccines including hemoglobin receptor
|
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌ｈ因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
|
WO2010109323A1
(en)
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Adjuvanting meningococcal factor h binding protein
|
|
JP5883380B2
(ja)
|
2009-04-30 |
2016-03-15 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
キメラ因子ｈ結合タンパク質（ｆｈｂｐ）およびその使用方法
|
|
US9365885B2
(en)
|
2009-06-16 |
2016-06-14 |
Puiying Annie Mak |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
|
US20110076300A1
(en)
|
2009-08-27 |
2011-03-31 |
Mariagrazia Pizza |
Hybrid Polypeptides Including Meningococcal fHBP Sequences
|
|
IT1395574B1
(it)
|
2009-09-14 |
2012-10-16 |
Guala Dispensing Spa |
Dispositivo di erogazione
|
|
US20130022639A1
(en)
|
2009-09-30 |
2013-01-24 |
Novartis Ag |
Expression of meningococcal fhbp polypeptides
|
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
|
JP3158225U
(ja)
*
|
2009-10-22 |
2010-03-25 |
王 文燦 |
折畳める物置袋
|
|
AU2010310985B2
(en)
|
2009-10-27 |
2014-11-06 |
Glaxosmithkline Biologicals S.A. |
Modified meningococcal fHBP polypeptides
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
BR112012022669A2
(pt)
|
2010-03-10 |
2017-02-14 |
Glaxosmithkline Biologicals Sa |
composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina.
|
|
BR112012022896A2
(pt)
|
2010-03-18 |
2018-03-27 |
Novartis Ag |
vacinas adjuvantes para meningococos do sorogrupo b
|
|
WO2011126863A1
(en)
|
2010-03-30 |
2011-10-13 |
Children's Hospital & Research Center Oakland |
Factor h binding proteins (fhbp) with altered properties and methods of use thereof
|
|
AU2011268507B2
(en)
|
2010-06-25 |
2014-08-14 |
Novartis Ag |
Combinations of meningococcal factor H binding proteins
|
|
DK3831406T3
(da)
|
2010-08-23 |
2024-06-17 |
Wyeth Llc |
Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener
|
|
ES2744471T3
(es)
|
2010-09-04 |
2020-02-25 |
Glaxosmithkline Biologicals Sa |
Ensayos de anticuerpos bactericidas para evaluar la inmunogenia y la potencia de vacunas de sacárido capsular meningocócico
|
|
US20120070457A1
(en)
|
2010-09-10 |
2012-03-22 |
J. Craig Venter Institute, Inc. |
Polypeptides from neisseria meningitidis
|
|
ES2728282T3
(es)
|
2010-09-10 |
2019-10-23 |
Wyeth Llc |
Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
|
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
|
CA2810971C
(en)
|
2010-09-10 |
2020-11-03 |
Novartis Ag |
Developments in meningococcal outer membrane vesicles
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
US20140112950A1
(en)
|
2011-03-02 |
2014-04-24 |
Manmohan Singh |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
US9181308B2
(en)
|
2011-03-28 |
2015-11-10 |
St. Jude Children's Research Hospital |
Methods and compositions employing immunogenic fusion proteins
|
|
MY198910A
(en)
|
2012-03-09 |
2023-10-02 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
|
US9965924B2
(en)
|
2013-07-15 |
2018-05-08 |
Ahmnon D. Moskowitz |
Methods, systems, and apparatus for playing multi-zone 21
|
|
KR20180099912A
(ko)
|
2013-09-08 |
2018-09-05 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
|
EP3270959A1
(en)
|
2015-02-19 |
2018-01-24 |
Pfizer Inc |
Neisseria meningitidis compositions and methods thereof
|
|
SG10202111092UA
(en)
|
2017-01-31 |
2021-11-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|